Copertina

Study finds no link between prenatal antidepressant exposure and childhood depression

Fuente: Wiley Open Access

Salvato in:

Dettagli Bibliografici
Natura:	Artículo Open Access
Pubblicazione:	Wiley 2025
Soggetti:	The Brown University Psychopharmacology Update
Accesso online:	Acceder al recurso
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi

Study finds association between levonorgestrel exposure, depression
Pubblicazione: (2024)

Review confirms antidepressant efficacy in post‐MI depression
Pubblicazione: (2025)

First‐line antidepressants decrease fall risk in elderly with depression
Pubblicazione: (2024)

Stopping antidepressant in pregnancy not linked to adverse postpartum outcomes
Pubblicazione: (2024)

Antimicrobial exposure and risk of depression
di: Y. W. Francis Lam
Pubblicazione: (2025)

Cohort study: No causal link between psychotropic exposure and obstetric complications
Pubblicazione: (2026)

Age an important variable in response to antidepressants
Pubblicazione: (2025)

Study: First‐trimester exposure to Z‐drugs not linked to congenital malformations
Pubblicazione: (2026)

Treatment of late‐life depression improves cognitive function, review finds
Pubblicazione: (2024)

Lead exposure associated with depression during later childhood
di: Alison Knopf
Pubblicazione: (2026)

Alcohol use history predicts antidepressant response to ketamine
Pubblicazione: (2026)

Impact of antidepressants' serotonin transporter affinity on bleeding events
di: Y. W. Francis Lam
Pubblicazione: (2026)

Gepirone ER not linked to sexual dysfunction in patients with depression
Pubblicazione: (2024)

Repetitive TMS more effective than antidepressant switch in nonresponders
Pubblicazione: (2024)

Comparative study of antidepressant deprescribing strategies favors slow tapering
Pubblicazione: (2026)

Paternal exposure to valproate not linked to child neurodevelopmental disorders
Pubblicazione: (2025)

Stimulant exposure in utero not linked to child neurodevelopmental disorders
Pubblicazione: (2024)

When both treatments unblinded, psychedelics not more effective than antidepressants
Pubblicazione: (2026)

Small differences in weight gain risk among commonly used antidepressants
Pubblicazione: (2024)

Study finds low correspondence between known genetic variations and treatment targets
Pubblicazione: (2025)

Fast‐acting psychedelic shows antidepressant effects in Phase 2A trial
Pubblicazione: (2025)

Paternal exposure to valproate linked to higher risk of neurodevelopmental disorders in offspring
Pubblicazione: (2026)

Prenatal exposure to benzodiazepines linked to long‐term risk of neurodevelopmental disorders
Pubblicazione: (2026)

Analysis finds benzodiazepine use in pregnancy linked to higher risk of preterm birth
Pubblicazione: (2026)

Study finds semaglutide not associated with higher risk of suicidality
Pubblicazione: (2024)

Study finds sustained effects of LSD‐assisted therapy on anxiety
Pubblicazione: (2024)

Study finds gabapentinoid treatment does not elevate risk of self‐harm
Pubblicazione: (2025)

Study of children exposed to SSRIs during breastfeeding finds no cognitive risk
Pubblicazione: (2026)

Pharmacological treatments for psychotic depression
di: Y. W. Francis Lam
Pubblicazione: (2024)

Fremanezumab effective for comorbid migraine and depression
Pubblicazione: (2025)

Esketamine monotherapy efficacious in treatment‐resistant depression
Pubblicazione: (2025)

Pharmacogenomic testing influenced prescribing in patients with depression
Pubblicazione: (2025)

Lumateperone effective as adjunctive therapy in patients with depression
Pubblicazione: (2025)

Postpartum hormonal contraceptives increase risk of depression
Pubblicazione: (2025)

Postpartum use of dexmedetomidine reduces incidence of depression
Pubblicazione: (2024)

Adjunctive aticaprant reduces symptoms in patients with depression
Pubblicazione: (2024)

Control group improvement lower in psilocybin trials for depression
Pubblicazione: (2025)

Antidepressants for bipolar depression do not increase risk of mania
Pubblicazione: (2024)

Mixed results for esmethadone in Phase 3 depression trial
Pubblicazione: (2024)

Adjunctive dextromethorphan/quinidine promising in pilot study for depression
Pubblicazione: (2024)